C07K 14/58
Atrial natriuretic factor complex
Official title: Atrial natriuretic factor complex; Atriopeptin; Atrial natriuretic peptide [ANP]; Cardionatrin; Cardiodilatin
C07K14/58 (Atrial natriuretic factor complex) appears on 208 US grants and 216 published applications in this corpus.
Search patents in C07K- Granted patents
- 208
- Published applications
- 216
- Assignees
- 130
- Inventors
- 505
- Latest grant
- 9 Sep 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1985 | 3 | 0 |
| 1986 | 3 | 0 |
| 1987 | 9 | 0 |
| 1988 | 9 | 0 |
| 1989 | 5 | 0 |
| 1990 | 6 | 0 |
| 1991 | 6 | 0 |
| 1992 | 9 | 0 |
| 1993 | 7 | 0 |
| 1994 | 8 | 0 |
| 1995 | 4 | 0 |
| 1996 | 2 | 0 |
| 1997 | 4 | 0 |
| 1998 | 4 | 0 |
| 1999 | 2 | 0 |
| 2000 | 8 | 0 |
| 2001 | 1 | 0 |
| 2002 | 4 | 3 |
| 2003 | 3 | 9 |
| 2004 | 1 | 4 |
| 2005 | 3 | 2 |
| 2006 | 0 | 13 |
| 2007 | 5 | 9 |
| 2008 | 3 | 9 |
| 2009 | 3 | 12 |
| 2010 | 8 | 24 |
| 2011 | 7 | 14 |
| 2012 | 5 | 10 |
| 2013 | 12 | 12 |
| 2014 | 8 | 10 |
| 2015 | 6 | 8 |
| 2016 | 10 | 11 |
| 2017 | 6 | 9 |
| 2018 | 9 | 8 |
| 2019 | 3 | 8 |
| 2020 | 2 | 4 |
| 2021 | 6 | 8 |
| 2022 | 6 | 9 |
| 2023 | 0 | 6 |
| 2024 | 3 | 8 |
| 2025 | 5 | 6 |
By publication year. Applications have been published since 2001.
Subgroups
Granted patents
Recent patents
- Natriuretic peptide receptor 1 antibodies and methods of use9 Sep 2025US 12,410,255 B2Novartis AG
- Brain natriuretic peptide engrafted antibodies19 Aug 2025US 12,390,508 B2Boehringer Ingelheim International GmbH
- Nucleic acids encoding anchor modified antibodies and uses thereof29 Jul 2025US 12,371,475 B2Regeneron Pharmaceuticals, Inc.
- Atrial natriuretic peptide engrafted antibodies17 Jun 2025US 12,331,094 B2Bayer Aktiengesellschaft
- Use of c-type natriuretic peptide variants to treat osteoarthritis4 Feb 2025US 12,214,015 B2Biomarin Pharmaceutical Inc.
- Combination treatment for resistant hypertension18 Dec 2025US 2025/0381249 A1Mayo Foundation for Medical Education and Research
- Atrial natriuretic peptide engrafted antibodies27 Nov 2025US 2025/0361282 A1Bayer Aktiengesellschaft
- Nucleic acids encoding anchor modified antibodies and uses thereof2 Oct 2025US 2025/0304656 A1Regeneron Pharmaceuticals, Inc.
- C-type natriuretic peptide engrafted antibodies24 Jul 2025US 2025/0236654 A1Bayer Aktiengesellschaft
- Cnp prodrugs with large carrier moieties24 Apr 2025US 2025/0127859 A1Ascendis Pharma Growth Disorders A/S
Most cited
By later US patents
- Novel atrial natriuretic/vasodilator polypeptides181US 4,764,504 ABiotechnology Research Associates, J.V. · 1988
- Natriuretic polypeptides125US 7,754,852 B2Mayo Foundation for Medical Education and Research · 2010
- Method and composition for treatment of skeletal dysplasias74US 7,276,481 B2ProChon Biotech Ltd. · 2007
- BNP antibody and immunoassay using it68US 5,786,163 AMedinnova SF · 1998
- Chimeric natriuretic peptides67US 6,818,619 B2Mayo Foundation for Medical Education and Research · 2004